Patients with acute cerebral ischemia are at high risk of recurrent ischemic events, particularly ischemic stroke^1–6 and current international guidelines recommend antiplatelet therapy for secondary prevention in patients with acute stroke or transient ischemic attack (TIA) of non-cardioembolic origin. Aspirin is the only antiplatelet agent that has received a class 1A recommendation.^7–9

中文翻译：

---

急性小号吨洛克或瞬态电流Isc ħ主位攻击抽动治疗一个GRE升或与阿司匹林镨Ë的vention小号troke和死亡（THALES）试验：基本原理和设计

患有急性脑缺血的患者经常发生缺血事件的风险很高，尤其是缺血性卒中^1–6，目前的国际指南建议对非心脏栓塞性急性卒中或短暂性脑缺血发作（TIA）的患者进行二级预防的抗血小板治疗。阿司匹林是唯一获得1A类推荐的抗血小板药物。^7–9